FORTAZ (Cardinal Health)
Welcome to the PulseAid listing for the FORTAZ drug offered from Cardinal Health. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cardinal Health |
NON-PROPRIETARY NAME: | ceftazidime |
SUBSTANCE NAME: | CEFTAZIDIME SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1992-08-26 |
END MARKETING DATE: | 0000-00-00 |
FORTAZ HUMAN PRESCRIPTION DRUG Details:
Item Description | FORTAZ from Cardinal Health |
LABELER NAME: | Cardinal Health |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 1992-08-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55154-1125_fd2fa2af-5929-4152-afd3-55e4e162f765 |
PRODUCT NDC: | 55154-1125 |
APPLICATION NUMBER: | NDA050578 |
Other CEFTAZIDIME SODIUM Pharmaceutical Manufacturers / Labelers: